My Account Log in

4 options

Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders : workshop summary / Sheena M. Posey Norris [and three others], rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy.

EBSCOhost Academic eBook Collection (North America) Available online

View online

Ebook Central Academic Complete Available online

View online

NCBI Bookshelf Available online

View online

National Academies Press Available online

View online
Format:
Book
Conference/Event
Author/Creator:
Norris, Sheena M. Posey, rapporteur.
Contributor:
Norris, Sheena M. Posey, contributor.
Institute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
Conference Name:
Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders (Workshop) (2015 : Washington, D.C.), author.
Language:
English
Subjects (All):
Pharmaceutical industry--Economic aspects.
Pharmaceutical industry.
Drug development--Economic aspects.
Drug development.
Central nervous system--Diseases--Effect of drugs on.
Central nervous system.
Public-private sector cooperation.
Physical Description:
1 online resource (128 p.)
Edition:
1st ed.
Place of Publication:
Washington, District of Columbia : The National Academies Press, 2015.
Language Note:
English
Summary:
The Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20-21, 2015, to explore policy changes that might increase private sector investment in research and development innovation that fills unmet medical needs for central nervous system (CNS) disorders. Workshop participants strategized about how to incentivize companies to fortify their CNS drug development programs, shrinking obstacles that currently deter ventures. Representatives from academia,government agencies, patient groups, and industry gathered to share information and viewpoints, and to brainstorm about budget-neutral policy changes that could help widen the pipeline toward drugs that address unmet needs for CNS disorders. This report summarizes the presentations and discussion of the workshop.
Contents:
FrontMatter; Reviewers; Contents; 1 Introduction and Overview; 2 Improving Market Protection; 3 Strengthening the Regulatory Pathway; 4 Patient Benefit and Engagement; Appendix A: References; Appendix B: Workshop Agenda; Appendix C: Registered Attendees; Appendix D: Participant Biographies
Notes:
Description based upon print version of record.
Includes bibliographical references.
Description based on online resource; title from PDF title page (ebrary, viewed March 17, 2016).
ISBN:
0-309-37326-3
0-309-37324-7

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account